A new study has identified an enzyme that plays an important role in breaking down unneeded or damaged proteins in the heart – an important process for maintaining heart health.

Scientists improved enzyme-based biosensors by modifying MOFs to enhance electron transfer and enzyme stability. Enzymes are ...

A new ML-guided platform can design thousands of new enzymes, predict how they will behave in the real world, and test their ...

A gene regulating testosterone in ruffs produces three male morphs with unique behaviors, offering insights into vertebrate ...

A single gene that regulates testosterone levels in a "crazy" species of shore bird controls the development of three wildly ...

What is ALPK2, and how can it help treat heart failure? Researchers have found that this heart-specific enzyme may prevent ...

Ecovyst (ECVT) and ChiralVision are pleased to announce the signing of a Memorandum of Understanding to enhance collaboration in the field of ...

Researchers from the Nagoya University Graduate School of Medicine identified an enzyme, alpha-kinase 2 (ALPK2) that is ...

Ecovyst Inc. (NYSE: ECVT), a leading integrated and innovative global provider of advanced materials, specialty catalysts, sulfuric acid and regeneration services ("Ecovyst"), and ChiralVision B.V., a ...

The global enzyme replacement therapy market size was valued at USD 10.12 billion in 2024 and is projected to grow from USD 11.35 billion in 2025 to reach USD 21.29 billion by 2033, exhibiting a CAGR ...

A new study has identified an enzyme that plays an important role in breaking down unneeded or damaged proteins in the heart -- an important process for maintaining heart health.

For the last 10 years, the only effective treatment for hypophosphatasia (HPP) has been an enzyme replacement therapy that ...